TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Novo Nordisk Pharmatech A/S
Closing information (x1000 SEK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
895,294
|
851,405
|
900,923 |
Earnings before taxes |
73,709
|
201,763
|
197,216 |
Total assets |
1,446,971
|
880,067
|
1,005,889 |
Current assets |
753,803
|
339,723
|
514,355 |
Current liabilities |
350,523
|
124,515
|
146,555 |
Equity capital |
1,032,003
|
715,479
|
818,222 |
- share capital |
14,966
|
13,753
|
13,492 |
Employees (average) |
150
![]() |
150
![]() |
150 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
71.3%
|
81.3%
![]() |
81.3% |
Turnover per employee |
5,969
|
5,676
|
6,006 |
Profit as a percentage of turnover |
8.2%
|
23.7%
|
21.9% |
Return on assets (ROA) | |||
Current ratio |
215.1%
|
272.8%
|
351.0% |
Return on equity (ROE) |
7.1%
|
28.2%
|
24.1% |
Change turnover |
-31,154
|
-66,901
|
63,059 |
Change turnover % |
-3%
|
-7%
|
8% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.